...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith-Oncology Pipeline

As there currently isn't any real market for Zenith other than the OTC I would say that the value is what someone would pay for a LARGE  # of shares, not the paltry few thousand that trade daily.

Market Cap is just math. Shares outstanding x price.  It's not a guesstimate of what people hope/think the company might be worth.  Some folks think the ZHCLF price is artifically low, but if just a handful of buyers thought it was a bargain, the price would zoom up because of the low liquidity. IMO the price reflects the untrue rumours that come and go, and the lack of confidence that we will see "unlocked shareholder value" in our pockets anytime in the foreseeable future.

 

Share
New Message
Please login to post a reply